| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.177 | 52 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.8165 | 40 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.3621 | 55 |
| GSM780719 | Untreated after 4 days (C1_2) | 56.5629 | 61 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.0667 | 37 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.859 | 21 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.0746 | 27 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.5302 | 25 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 52.9118 | 56 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 52.9829 | 56 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.1639 | 23 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.3253 | 42 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.1606 | 56 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.3752 | 34 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.719 | 51 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.4183 | 34 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.5374 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.6618 | 44 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.8152 | 40 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.5571 | 11 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.7064 | 40 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.0575 | 27 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.9755 | 48 |